Shareholder alert: pomerantz law firm investigates claims on behalf of investors of acelrx pharmaceuticals, inc. (acrx)

New york, new york--(newsfile corp. - march 14, 2021) - pomerantz llp is investigating claims on behalf of investors of acelrx pharmaceuticals, inc. ("acelrx" or the "company") (nasdaq: acrx). such investors are advised to contact robert s. willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.the investigation concerns whether acelrx and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [click here for information about joining the...
ACRX Ratings Summary
ACRX Quant Ranking